Skip to content

Validation study of a program to prevent severe hypertension 2

Validation study of a program to prevent severe hypertension 2 - Validation study of a program to prevent severe hypertension 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054509
Enrollment
100
Registered
2024-05-30
Start date
2024-07-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Sponsors

General Incorporated Association telemedEASE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Members of the health insurance association of companies agreeing with this study(non-family) 3.Persons who are at high risk of developing one of the following five events in the next three years: myocardial infarction or cerebral hemorrhage or stroke or aortic aneurysm/dissection or heart failure (Persons who meet either (1)or (2) or (3)below) (1)Persons who are in the top 5% at risk of developing the event and whose systolic blood pressure is 140 mmHg or higher or diastolic blood pressure is 90 mmHg or higher according to the results of the most recent medical checkup. (2)Persons who are in the top 10% at risk of developing the event and whose systolic blood pressure is 160 mmHg or higher or diastolic blood pressure is 100 mmHg or higher according to the results of the most recent medical checkup. (3)Persons with systolic blood pressure of 140 mmHg or higher or diastolic blood pressure of 90 mmHg or higher as a result of the most recent medical checkup and who are at "high risk" for cerebrovascular disease based on hypertension treatment guidelines. 4.Regardless of the condition in (3), hypertensive patients who meet the conditions set by the companies and health insurance associations participating in this study. 5.Persons who can participate in the online conference via own smartphone, tablet, or computer.

Exclusion criteria

Exclusion criteria: 1.Persons who are participating in other health programs such as specific health guidance and serious illness prevention programs conducted by Health Insurance Association 2.Persons who are participating in other clinical trials 3.Persons who have already experienced the onset of the following events Event onset: myocardial infarction, cerebral hemorrhage, stroke, aortic aneurysm/dissection, heart failure 4.Persons with persistent atrial fibrillation 5.Secondary hypertension (excluding idiopathic aldosteronism) 6.Persons with other serious diseases 7.Persons who are pregnant or breastfeeding 8.Persons who are deemed inappropriate by the industrial physician or industrial nurse at their company or office 9.Persons who were judged as inappropriate for study participants by the principal investigator

Design outcomes

Primary

MeasureTime frame
Achievement rate of home blood pressure less than 135/85 mmHg Participation rate Completion rate

Secondary

MeasureTime frame
Home blood pressure (e.g., amount of blood pressure reduction from baseline) Percentage of patients receiving online medical care Rate of continuation of home blood pressure measurement Percentage of patients who continue to take their medications Improvement rate of event risk(Myocardial infarction, cerebral hemorrhage, cerebral infarction, aortic aneurysm/dissection, and heart failure) Detect three types of suspected arrhythmia (bradycardia, tachycardia, and atrial fibrillation) Number of introduction to medical institutions on detection of arrhythmia

Countries

Japan

Contacts

Public ContactJunichi Yatabe

General Incorporated Association telemedEASE Representative Director

supportjyatabe@telemedease.org050-3528-8158

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026